Counting the days till Zyprexa's patent runs out

The Zyprexa countdown nears its end. As the Indianapolis Star reports, there are only 21 days remaining on the blockbuster antipsychotic's patent, meaning Eli Lilly will soon face copycat rivals to its biggest-selling medication ever. Report